An insight into the pathophysiology of thrombosis in antiphospholipid syndrome

Frontiers in Bioscience

Volumn 12, Issue 8, 2007, Pages 3093-3103

  Palomo, Ivan G ^a   Segovia, Fabian M ^a   Alarcon, Marcelo L ^a   Fuentes, Barbara Y ^a   Pereira, Jaime G ^b   Rojas, Armando ^c   Forastiero, Ricardo ^d  

^a UNIVERSIDAD DE TALCA   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD CATÓLICA DEL MAULE   (Chile)

^d FAVALORO UNIVERSITY   (Argentina)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Beta 2 glycoprotein I; Review; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; AUTOANTIGEN;

ANTIGEN ANTIBODY REACTION; ANTIPHOSPHOLIPID SYNDROME; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; REVIEW; THROMBOSIS;

ANTICOAGULANTS; ANTIGEN-ANTIBODY REACTIONS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIGENS; HUMANS; THROMBOSIS;

EID: 34347233811     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2297     Document Type: Review

References (118)

1. Palomo, I., J. Pereira, M. Alarcon, M. Vasquez, C. Pinochet, M. T. Velez, J. Sandoval, G. Icaza & S. Pierangeli: Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis. Clin Rheumatol, 23, 129-33 (2004) (Pubitemid 38559183)
2. Bidot, C. J., W. Jy, L. L. Horstman, E. R. Ahn, L. Bidot, V. Fontana & Y. S. Ahn: Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia. Hematology, 10, 451-6 (2005) (Pubitemid 43123467)
3. Ortel, T. L.: Thrombosis and the antiphospholipid syndrome. Hematology (Am Soc Hematol Educ Program) 462-8 (2005)
4. Arnout, J. & J. Vermylen: Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Thromb Haemost, 1, 931-42 (2003)
5. de Groot, P. G. & R. H. Derksen: Antiphospholipid antibodies: update on detection, pathophysiology, and treatment. Curr Opin Hematol, 11, 165-9 (2004) (Pubitemid 38952004)
6. Hughes, G. R.: The antiphospholipid syndrome: ten years on. Lancet, 342, 341-4 (1993) (Pubitemid 23227565)
7. Wilson, W. A., A. E. Gharavi, T. Koike, M. D. Lockshin, D. W. Branch, J. C. Piette, R. Brey, R. Derksen, E. N. Harris, G. R. Hughes, D. A. Triplett & M. A. Khamashta: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 42, 1309-11 (1999) (Pubitemid 30265586)
8. Harris, E. N. & M. Khamashta: Anticardiolipin test and the antiphospholipid (Hughes) syndrome: 20 years and counting! J Rheumatol, 31, 2099-101 (2004) (Pubitemid 39453224)
9. Harris, E. N., S. S. Peirangeli & A. E. Gharavi: Antiphospholipid syndrome: diagnosis, pathogenesis, and management. J Med Assoc Ga, 91, 31-4 (2002)
10. Miyakis, S., M. D. Lockshin, T. Atsumi, D. W. Branch, R. L. Brey, R. Cervera, R. H. Derksen, D. E. G. PG, T. Koike, P. L. Meroni, G. Reber, Y. Shoenfeld, A. Tincani, P. G. Vlachoyiannopoulos & S. A. Krilis: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost, 4, 295-306 (2006)
11. Brandt, J. T., D. A. Triplett, B. Alving & I. Scharrer: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost, 74, 1185-90 (1995)
12. Harris, E. N.: Special report. The Second International Anticardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol, 94, 476-84 (1990) (Pubitemid 20316579)
13. Palomo, I., J. Pereira, M. Alarcon, M. Vasquez & S. Pierangeli: Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis. Nephron, 92, 957-8 (2002) (Pubitemid 36151390)
14. Palomo, I. G., V. E. Mujica, M. L. Alarcon, J. G. Pereira & M. R. Vasquez: Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals. J Diabetes Complications, 19, 133-7 (2005) (Pubitemid 40615543)
15. McIntyre, J. A., D. R. Wagenknech & D. W. Waxman: Frequency and specificities of antiphospholipid antibodies (aPL) in volunteer blood donors. Immunobiology, 207, 59-63 (2003) (Pubitemid 36285098)
16. Matsuura, E., Y. Igarashi, T. Yasuda, D. A. Triplett & T. Koike: Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med, 179, 457-62 (1994) (Pubitemid 24058733)
17. Bevers, E. M., M. Galli, T. Barbui, P. Comfurius & R. F. Zwaal: Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost, 66, 629-32 (1991)
18. Galli, M., G. M. Willems, J. Rosing, R. M. Janssen, J. W. Govers-Riemslag, P. Comfurius, T. Barbui, R. F. Zwaal & E. M. Bevers: Anti-prothrombin IgG from patients with antiphospholipid antibodies inhibits the inactivation of factor Va by activated protein C. Br J Haematol, 129, 240-7 (2005) (Pubitemid 40562445)
19. Rand, J. H. & X. X. Wu: Antibody-mediated interference with annexins in the antiphospholipid syndrome. Thromb Res, 114, 383-9 (2004) (Pubitemid 39422570)
20. Adams, M., L. Breckler, P. Stevens, J. Thom, R. Baker & R. Oostryck: Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation. Haematologica, 89, 985-90 (2004) (Pubitemid 39049908)
21. Cugno, M., M. Cabibbe, M. Galli, P. L. Meroni, S. Caccia, R. Russo, B. Bottasso & P. M. Mannucci: Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood, 103, 2121-6 (2004) (Pubitemid 38326228)
22. Yang, C. D., K. K. Hwang, W. Yan, K. Gallagher, J. FitzGerald, J. M. Grossman, B. H. Hahn & P. P. Chen: Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J Immunol, 172, 5765-73 (2004) (Pubitemid 38542082)
23. Sugi, T. & J. A. McIntyre: Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens. J Autoimmun, 17, 207-14 (2001) (Pubitemid 33108756)
24. Bidot, C. J., W. Jy, L. L. Horstman, H. Huisheng, J. J. Jimenez, M. Yaniz & Y. S. Ahn: Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome. Br J Haematol, 120, 618-26 (2003) (Pubitemid 36255862)
25. Sugi, T. & T. Makino: Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review. Am J Reprod Immunol, 47, 283-8 (2002) (Pubitemid 34466994)
26. Hunt, J. & S. Krilis: The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol, 152, 653-9 (1994)
27. Sheng, Y., A. Sali, H. Herzog, J. Lahnstein & S. A. Krilis: Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol, 157, 3744-51 (1996) (Pubitemid 126449192)
28. Gushiken, F. C., A. Le, F. C. Arnett & P. Thiagarajan: Polymorphisms beta2-glycoprotein I: phospholipid binding and multimeric structure. Thromb Res, 108, 175-80 (2002) (Pubitemid 36184654)
29. Carreras, L. O., R. R. Forastiero & M. E. Martinuzzo: Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun, 15, 163-72 (2000)
30. Lowe, G. D., A. Rumley & I. J. Mackie: Plasma fibrinogen. Ann Clin Biochem, 41, 430-40 (2004) (Pubitemid 39573999)
31. Dahlback, B. & B. O. Villoutreix: The anticoagulant protein C pathway. FEBS Lett, 579, 3310-6 (2005) (Pubitemid 40804679)
32. Dahlback, B. & B. O. Villoutreix: Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol, 25, 1311-20 (2005) (Pubitemid 40923345)
33. Malia, R. G., S. Kitchen, M. Greaves & F. E. Preston: Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol, 76, 101-7 (1990) (Pubitemid 20326802)
34. Brenner, B.: Haemostatic changes in pregnancy. Thromb Res, 114, 409-14 (2004) (Pubitemid 39422573)
35. Rand, J. H.: Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. J Autoimmun, 15, 107-11 (2000)
36. Brachvogel, B., J. Dikschas, H. Moch, H. Welzel, K. von der Mark, C. Hofmann & E. Poschl: Annexin A5 is not essential for skeletal development. Mol Cell Biol, 23, 2907-13 (2003) (Pubitemid 36403087)
37. Cesarman-Maus, G. & K. A. Hajjar: Molecular mechanisms of fibrinolysis. Br J Haematol, 129, 307-21 (2005) (Pubitemid 40646889)
38. Giannakopoulos, B., F. Passam, S. Rahgozar & S. Krilis: Current Concepts On The Pathogenesis Of The Antiphospholipid Syndrome. Blood, Prepublished online, (2006)
39. Cline, A. M. & M. Z. Radic: Apoptosis, subcellular particles, and autoimmunity. Clin Immunol, 112, 175-82 (2004) (Pubitemid 38881483)
40. Bevers, E. M., M. P. Janssen, P. Comfurius, K. Balasubramanian, A. J. Schroit, R. F. Zwaal & G. M. Willems: Quantitative determination of the binding of beta2-glycoprotein I and prothrombin to phosphatidylserineexposing blood platelets. Biochem J, 386, 271-9 (2005) (Pubitemid 40343784)
41. Price, B. E., J. Rauch, M. A. Shia, M. T. Walsh, W. Lieberthal, H. M. Gilligan, T. O'Laughlin, J. S. Koh & J. S. Levine: Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein Idependent manner. J Immunol, 157, 2201-8 (1996) (Pubitemid 126449701)
42. Levine, J. S., R. Subang, J. S. Koh & J. Rauch: Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes. J Autoimmun, 11, 413-24 (1998) (Pubitemid 28520196)
43. D'Agnillo, P., J. S. Levine, R. Subang & J. Rauch: Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies. J Immunol, 170, 3408-22 (2003) (Pubitemid 36302221)
44. Hattori, N., M. Kuwana, J. Kaburaki, T. Mimori, Y. Ikeda & Y. Kawakami: T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum, 43, 65-75 (2000) (Pubitemid 30368214)
45. Buttari, B., E. Profumo, V. Mattei, A. Siracusano, E. Ortona, P. Margutti, B. Salvati, M. Sorice & R. Rigano: Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood, 106, 3880-7 (2005) (Pubitemid 41739027)
46. Blank, M., I. Krause, M. Fridkin, N. Keller, J. Kopolovic, I. Goldberg, A. Tobar & Y. Shoenfeld: Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest, 109, 797-804 (2002) (Pubitemid 34263156)
47. Font, J., G. Espinosa, D. Tassies, M. Pino, M. A. Khamashta, T. Gallart, R. Cervera, G. Escolar, G. R. Hughes, M. Ingelmo, A. Ordinas & J. C. Reverter: Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions. Arthritis Rheum, 46, 3283-9 (2002) (Pubitemid 35453538)
48. Bevers, E. M., R. F. Zwaal & G. M. Willems: The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin. Clin Immunol, 112, 150-60 (2004) (Pubitemid 38881480)
49. Molino, D., N. G. De Santo, R. Marotta, P. Anastasio, M. Mosavat & D. De Lucia: Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients. Semin Nephrol, 24, 495-501 (2004) (Pubitemid 39361062)
50. Le, A., S. Dasgupta, S. Planque, S. Paul & P. Thiagarajan: Lupus-derived antiprothrombin autoantibodies from a V gene phage display library are specific for the kringle 2 domain of prothrombin. Biochemistry, 43, 4047-54 (2004) (Pubitemid 38437071)
51. Safa, O., C. T. Esmon & N. L. Esmon: Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies. Blood, 106, 1629-35 (2005) (Pubitemid 41208575)
52. de Groot, P. G. & R. H. Derksen: Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost, 3, 1854-60 (2005) (Pubitemid 41716572)
53. Amengual, O., T. Atsumi, M. A. Khamashta & G. R. Hughes: The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost, 79, 276-81 (1998) (Pubitemid 28065869)
54. Forastiero, R. R., M. E. Martinuzzo & G. J. Broze: High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome. J Thromb Haemost, 1, 718-24 (2003)
55. Adams, M. J., S. Donohoe, I. J. Mackie & S. J. Machin: Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome. Br J Haematol, 114, 375-9 (2001) (Pubitemid 32762239)
56. Rand, J. H., X. X. Wu, S. Guller, J. Gil, A. Guha, J. Scher & C. J. Lockwood: Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol, 171, 1566-72 (1994)
57. Ieko, M., K. Ichikawa, T. Atsumi, R. Takeuchi, K. I. Sawada, T. Yasukouchi & T. Koike: Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis. Semin Thromb Hemost, 26, 85-90 (2000) (Pubitemid 30238023)
58. Koike, T.: Anticardiolipin antibodies in NZW x BXSB F1 mice. Lupus, 3, 241-6 (1994) (Pubitemid 24277034)
59. Monestier, M., D. A. Kandiah, S. Kouts, K. E. Novick, G. L. Ong, M. Z. Radic & S. A. Krilis: Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J Immunol, 156, 2631-41 (1996)
60. Miyakis, S., S. A. Robertson & S. A. Krilis: Beta-2 glycoprotein I and its role in antiphospholipid syndromelessons from knockout mice. Clin Immunol, 112, 136-43 (2004) (Pubitemid 38881478)
61. George, J., A. Afek, B. Gilburd, Y. Levy, M. Blank, J. Kopolovic, D. Harats & Y. Shoenfeld: Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus, 6, 723-9 (1997) (Pubitemid 27511291)
62. Rao, L. V., A. D. Hoang & S. I. Rapaport: Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid. Blood, 88, 4173-82 (1996) (Pubitemid 26399163)
63. Hwang, K. K., J. M. Grossman, S. Visvanathan, R. U. Chukwuocha, V. L. Woods, Jr., D. T. Le, B. H. Hahn & P. P. Chen: Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol, 167, 7192-8 (2001) (Pubitemid 33144217)
64. Amengual, O., T. Atsumi & T. Koike: Antiprothombin antibodies and the diagnosis of antiphospholipid syndrome. Clin Immunol, 112, 144-9 (2004) (Pubitemid 38881479)
65. Rand, J. H., X. X. Wu, H. A. Andree, C. J. Lockwood, S. Guller, J. Scher & P. C. Harpel: Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N Engl J Med, 337, 154-60 (1997) (Pubitemid 27306286)
66. Huang, Z. F., D. Higuchi, N. Lasky & G. J. Broze, Jr.: Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood, 90, 944-51 (1997) (Pubitemid 27314126)
67. Sandset, P. M., B. J. Warn-Cramer, S. L. Maki & S. I. Rapaport: Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood, 78, 1496-502 (1991)
68. Sandset, P. M., B. J. Warn-Cramer, L. V. Rao, S. L. Maki & S. I. Rapaport: Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci U S A, 88, 708-12 (1991) (Pubitemid 21916092)
69. Oosting, J. D., R. H. Derksen, I. W. Bobbink, T. M. Hackeng, B. N. Bouma & P. G. de Groot: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood, 81, 2618-25 (1993) (Pubitemid 23147565)
70. Oosting, J. D., K. T. Preissner, R. H. Derksen & P. G. de Groot: Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitro. Br J Haematol, 85, 761-8 (1993) (Pubitemid 24003592)
71. Oganesyan, V., N. Oganesyan, S. Terzyan, D. Qu, Z. Dauter, N. L. Esmon & C. T. Esmon: The crystal structure of the endothelial protein C receptor and a bound phospholipid. J Biol Chem, 277, 24851-4 (2002) (Pubitemid 34951783)
72. Stearns-Kurosawa, D. J., S. Kurosawa, J. S. Mollica, G. L. Ferrell & C. T. Esmon: The endothelial cell protein C receptor augments protein C activation by the thrombinthrombomodulin complex. Proc Natl Acad Sci U S A, 93, 10212-6 (1996) (Pubitemid 26314601)
73. Gu, J. M., J. T. Crawley, G. Ferrell, F. Zhang, W. Li, N. L. Esmon & C. T. Esmon: Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. J Biol Chem, 277, 43335-43 (2002) (Pubitemid 35285721)
74. Hurtado, V., R. Montes, J. C. Gris, M. L. Bertolaccini, A. Alonso, M. A. Martinez-Gonzalez, M. A. Khamashta, K. Fukudome, D. A. Lane & J. Hermida: Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood, 104, 1369-74 (2004) (Pubitemid 39166513)
75. Yasuda, S., T. Atsumi, M. Ieko & T. Koike: Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis. Thromb Res, 114, 461-5 (2004)
76. Pierangeli, S. S., P. P. Chen & E. B. Gonzalez: Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol, 13, 366-375 (2006) (Pubitemid 44168459)
77. Zhang, J. & K. R. McCrae: Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood, 105, 1964-9 (2005) (Pubitemid 40731779)
78. Pierangeli, S. S. & E. N. Harris: Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus, 12, 539-45 (2003) (Pubitemid 36890147)
79. Pierangeli, S. S., R. G. Espinola, X. Liu & E. N. Harris: Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res, 88, 245-50 (2001) (Pubitemid 32147315)
80. Simantov, R., J. M. LaSala, S. K. Lo, A. E. Gharavi, L. R. Sammaritano, J. E. Salmon & R. L. Silverstein: Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest, 96, 2211-9 (1995)
81. Wang, C. R., M. F. Liu, R. T. Tsai, C. Y. Chuang & C. Y. Chen: Circulating intercellular adhesion molecules-1 and autoantibodies including anti-endothelial cell, anticardiolipin, and anti-neutrophil cytoplasma antibodies in patients with vasculitis. Clin Rheumatol, 12, 375-80 (1993)
82. Kaplanski, G., P. Cacoub, C. Farnarier, V. Marin, R. Gregoire, A. Gatel, J. M. Durand, J. R. Harle, P. Bongrand & J. C. Piette: Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis. Arthritis Rheum, 43, 55-64 (2000) (Pubitemid 30368213)
83. Delgado Alves, J., L. J. Mason, P. R. Ames, P. P. Chen, J. Rauch, J. S. Levine, R. Subang & D. A. Isenberg: Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model. Rheumatology (Oxford), 44, 1238-44 (2005) (Pubitemid 41487956)
84. Mercanoglu, F., D. Erdogan, H. Oflaz, R. Kucukkaya, F. Selcukbiricik, A. Gul & M. Inanc: Impaired brachial endothelial function in patients with primary antiphospholipid syndrome. Int J Clin Pract, 58, 1003-7 (2004) (Pubitemid 39642408)
85. George, J., N. Yacov, E. Breitbart, L. Bangio, A. Shaish, B. Gilburd, Y. Shoenfeld & D. Harats: Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. Cardiovasc Res, 62, 603-9 (2004) (Pubitemid 38648975)
86. Yasuda, S., M. Bohgaki, T. Atsumi & T. Koike: Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogenactivated protein kinase pathway. Immunobiology, 210, 775-80 (2005) (Pubitemid 41683862)
87. Miyakis, S., B. Giannakopoulos & S. A. Krilis: Beta 2 glycoprotein I-function in health and disease. Thromb Res, 114, 335-46 (2004) (Pubitemid 39422565)
88. Joseph, J. E., P. Harrison, I. J. Mackie, D. A. Isenberg & S. J. Machin: Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol, 115, 451-9 (2001) (Pubitemid 34203516)
89. Joseph, J. E., S. Donohoe, P. Harrison, I. J. Mackie & S. J. Machin: Platelet activation and turnover in the primary antiphospholipid syndrome. Lupus, 7, 333-40 (1998) (Pubitemid 28347013)
90. Pierangeli, S. S., M. Vega-Ostertag & E. N. Harris: Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb Res, 114, 467-76 (2004) (Pubitemid 39429425)
91. Espinola, R. G., S. S. Pierangeli, A. E. Gharavi & E. N. Harris: Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost, 87, 518-22 (2002) (Pubitemid 34232495)
92. Giesen, P. L., U. Rauch, B. Bohrmann, D. Kling, M. Roque, J. T. Fallon, J. J. Badimon, J. Himber, M. A. Riederer & Y. Nemerson: Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A, 96, 2311-5 (1999) (Pubitemid 29117911)
93. Drake, T., W. Ruf, J. Morrissey & T. Edgington: Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol, 109, 389-95 (1989) (Pubitemid 19180145)
94. Gregory, S. A., J. H. Morrissey & T. S. Edgington: Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol, 9, 2752-5 (1989) (Pubitemid 19148149)
95. Sabatier, F., V. Roux, F. Anfosso, L. Camoin, J. Sampol & F. Dignat-George: Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood, 99, 3962-70 (2002) (Pubitemid 35332035)
96. Lee, W. H., S. H. Kim, E. M. Jeong, Y. H. Choi, D. I. Kim, B. B. Lee, Y. S. Cho, B. S. Kwon & J. E. Park: A novel chemokine, Leukotactin-1, induces chemotaxis, proatherogenic cytokines, and tissue factor expression in atherosclerosis. Atherosclerosis, 161, 255-60 (2002) (Pubitemid 34219177)
97. Arepally, G. M. & I. M. Mayer: Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood, 98, 1252-4 (2001)
98. Khajuria, A. & D. S. Houston: Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood, 96, 966-72 (2000) (Pubitemid 30616861)
99. Celi, A., G. Pellegrini, R. Lorenzet, A. De Blasi, N. Ready, B. C. Furie & B. Furie: P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A, 91, 8767-71 (1994)
100. Schved, J. F., J. C. Gris, V. Ollivier, J. L. Wautier, G. Tobelem & J. Caen: Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant. Am J Hematol, 41, 92-6 (1992)
101. Kornberg, A., M. Blank, S. Kaufman & Y. Shoenfeld: Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies. J Immunol, 153, 1328-32 (1994) (Pubitemid 24228525)
102. Reverter, J. C., D. Tassies, J. Font, J. Monteagudo, G. Escolar, M. Ingelmo & A. Ordinas: Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s. Arterioscler Thromb Vasc Biol, 16, 1319-26 (1996) (Pubitemid 26378221)
103. Reverter, J. C., D. Tassies, J. Font, M. A. Khamashta, K. Ichikawa, R. Cervera, G. Escolar, G. R. Hughes, M. Ingelmo & A. Ordinas: Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum, 41, 1420-7 (1998) (Pubitemid 28373121)
104. Lackner, K. J., C. von Landenberg, S. Barlage & G. Schmitz: Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Thromb Haemost, 83, 583-8 (2000) (Pubitemid 30201135)
105. Ferro, D., M. Saliola, P. L. Meroni, G. Valesini, C. Caroselli, D. Pratico, G. A. Fitzgerald, Y. Shoenfeld & F. Violi: Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost, 1, 523-31 (2003)
106. Zhou, H., A. S. Wolberg & R. A. Roubey: Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood, 104, 2353-8 (2004) (Pubitemid 39331833)
107. Cuadrado, M. J., C. Lopez-Pedrera, M. A. Khamashta, M. T. Camps, F. Tinahones, A. Torres, G. R. Hughes & F. Velasco: Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum, 40, 834-41 (1997) (Pubitemid 27199998)
108. Dobado-Berrios, P. M., C. Lopez-Pedrera, F. Velasco, M. A. Aguirre, A. Torres & M. J. Cuadrado: Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost, 82, 1578-82 (1999)
109. Visvanathan, S. & H. P. McNeil: Cellular immunity to beta 2-glycoprotein-1 in patients with the antiphospholipid syndrome. J Immunol, 162, 6919-25 (1999) (Pubitemid 29309421)
110. Del Prete, G., M. De Carli, R. M. Lammel, M. M. D'Elios, K. C. Daniel, B. Giusti, R. Abbate & S. Romagnani: Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood, 86, 250-7 (1995)
111. Holers, V. M., G. Girardi, L. Mo, J. M. Guthridge, H. Molina, S. S. Pierangeli, R. Espinola, L. E. Xiaowei, D. Mao, C. G. Vialpando & J. E. Salmon: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med, 195, 211-20 (2002) (Pubitemid 34461265)
112. Salmon, J. E., G. Girardi & V. M. Holers: Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis, 61 Suppl 2, ii46-50 (2002) (Pubitemid 35221713)
113. Girardi, G., J. Berman, P. Redecha, L. Spruce, J. M. Thurman, D. Kraus, T. J. Hollmann, P. Casali, M. C. Caroll, R. A. Wetsel, J. D. Lambris, V. M. Holers & J. E. Salmon: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest, 112, 1644-54 (2003) (Pubitemid 38063722)
114. Pierangeli, S. S., G. Girardi, M. Vega-Ostertag, X. Liu, R. G. Espinola & J. Salmon: Requirement of activation of complement C3 and C5 for antiphospholipid antibodymediated thrombophilia. Arthritis Rheum, 52, 2120-4 (2005) (Pubitemid 40994335)
115. Grant, E. P., D. Picarella, T. Burwell, T. Delaney, A. Croci, N. Avitahl, A. A. Humbles, J. C. Gutierrez-Ramos, M. Briskin, C. Gerard & A. J. Coyle: Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med, 196, 1461-71 (2002) (Pubitemid 35424940)
116. Fischetti, F., P. Durigutto, V. Pellis, A. Debeus, P. Macor, R. Bulla, F. Bossi, F. Ziller, D. Sblattero, P. Meroni & F. Tedesco: Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood, 106, 2340-6 (2005) (Pubitemid 41510805)
117. Shinzato, M. M., C. Bueno, V. S. Trindade Viana, E. F. Borba, C. R. Goncalves & E. Bonfa: Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis. Lupus, 14, 953-8 (2005) (Pubitemid 43088269)
118. Girardi, G., P. Redecha & J. E. Salmon: Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med, 10, 1222-6 (2004) (Pubitemid 39540439)